The University of Kansas Cancer Center
The NCI comprehensive centre for Kansas and western Missouri, active in drug repurposing, triple-negative breast cancer trials and rural access.
NCI-designated in 2012 and comprehensive since 2022, KU Cancer Center covers Kansas and western Missouri and reaches rural communities through the Masonic Cancer Alliance. Priyanka Sharma leads SWOG triple-negative breast cancer trials from here, and the Institute for Advancing Medical Innovation runs drug discovery and repurposing programmes. Research strengths include liquid biopsy, cancer biology and clinical trials in haematologic malignancies and breast cancer. The centre partners with Children's Mercy Kansas City for paediatric oncology.
- Triple-negative breast cancer (SWOG)
- Drug repurposing
- Rural outreach (Masonic Cancer Alliance)
Pages like this
not linked directly; found by shared links- TrialSCARLET (SWOG S2212)
Shares Priyanka Sharma, SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- IdeaFix the neutrophil count rule that excludes many people of African ancestry
Shares Trials enrol too few, too slowly, Multiple myeloma, Triple-negative breast cancer (TNBC).
- PersonMariana Chavez-MacGregor
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- PersonDawn L. Hershman
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- IdeaBlock the recycling that keeps dormant cells alive
Shares No incentive to repurpose cheap drugs, Liquid biopsy (ctDNA), Triple-negative breast cancer (TNBC).
- TrialAdd-Aspirin
Shares Systematic drug repurposing, No incentive to repurpose cheap drugs.
- IdeaStop over-excluding people who could become pregnant; study pregnancy exposure
Shares Trials enrol too few, too slowly, Triple-negative breast cancer (TNBC).
- IdeaKidney and liver impairment dosing studies completed before approval, not years after